n-3 Fatty Acids in Cardiovascular DiseaseDE CATERINA, Raffaele.The New England journal of medicine. 2011, Vol 364, Num 25, pp 2439-2450, issn 0028-4793, 12 p.Article

Soluble adhesion molecules as markers of endothelial activation : what is their basic biology and can they help us predict vascular events?DE CATERINA, Raffaele.Dialogues in cardiovascular medicine. 2007, Vol 12, Num 4, pp 270-284, issn 1272-9949, 15 p.Article

EMERALD, AIMI, and PROMISE : is there still a potential for embolic protection in primary PCI?LIMBRUNO, Ugo; DE CATERINA, Raffaele.European heart journal. 2006, Vol 27, Num 10, pp 1139-1145, issn 0195-668X, 7 p.Article

Prolonged exposure to high insulin impairs the endothelial P13-kinase/Akt/nitric oxide signallingMADONNA, Rosalinda; DE CATERINA, Raffaele.Thrombosis and haemostasis. 2009, Vol 101, Num 2, pp 345-350, issn 0340-6245, 6 p.Article

Long-term treatment strategies for atherothrombotic disease : do platelets define the course?ZIMARINO, Marco; DE CATERINA, Raffaele.European heart journal supplements. 2008, Vol 10, Num I, issn 1520-765X, I8-I13Article

The long-term use of blockers of the platelet ADP receptor in acute coronary syndromesDE CATERINA, Raffaele; ZIMARINO, Marco.Haematologica (Roma). 2001, Vol 86, Num 11, pp 25-27, issn 0390-6078, SUP2Article

In vitro neovasculogenic potential of resident adipose tissue precursorsMADONNA, Rosalinda; DE CATERINA, Raffaele.American journal of physiology. Cell physiology. 2008, Vol 64, Num 5, issn 0363-6143, C1271-C1280Article

Stem cells and growth factor delivery systems for cardiovascular diseaseMADONNA, Rosalinda; DE CATERINA, Raffaele.Journal of biotechnology. 2011, Vol 154, Num 4, pp 291-297, issn 0168-1656, 7 p.Article

Clinical Use of Aspirin in Ischemic Heart Disease: Past, Present and FutureDE CATERINA, Raffaele; RENDA, Giulia.Current pharmaceutical design (Print). 2012, Vol 18, Num 33, pp 5215-5223, issn 1381-6128, 9 p.Article

Adipose Tissue-Derived Stem Cells: Characterization and Potential for Cardiovascular RepairMADONNA, Rosalinda; GENG, Yong-Jian; DE CATERINA, Raffaele et al.Arteriosclerosis, thrombosis, and vascular biology. 2009, Vol 29, Num 11, pp 1723-1729, issn 1079-5642, 7 p.Article

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetesBASTA, Giuseppina; SCHMIDT, Ann Marie; DE CATERINA, Raffaele et al.Cardiovascular research. 2004, Vol 63, Num 4, pp 582-592, issn 0008-6363, 11 p.Article

Fatty acid modulation of endothelial activationDE CATERINA, Raffaele; MASSARO, Marika.Biochemistry of lipids in vascular function 2004. 2004, pp 129-137, isbn 81-7736-234-8, 9 p.Book Chapter

Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stentsZIMARINO, Marco; RENDA, Giulia; DE CATERINA, Raffaele et al.Drugs (Basel). 2005, Vol 65, Num 6, pp 725-732, issn 0012-6667, 8 p.Article

Aspirin resistanceRENDA, Giulia; SCIARTILLI, Adolfo; DE CATERINA, Raffaele et al.Haematologica (Roma). 2003, Vol 88, pp 43-49, issn 0390-6078, 7 p., SUP4Article

Effects of oleic acid on endothelial activation: A possible mechanism for prevention of atherosclerosisMASSARO, Marika; DE CATERINA, Raffaele.Recent research developments in lipids. Vol. 5 (2000) ; Part I. Recent research developments in lipids. 2001, pp 85-96, isbn 81-86846-98-0Book Chapter

Stroke Prevention in Atrial Fibrillation: Current Status and Near-Future DirectionsDE CATERINA, Raffaele; HYLEK, Elaine M.The American journal of medicine. 2011, Vol 124, Num 9, pp 793-799, issn 0002-9343, 7 p.Article

Complete myocardial revascularization : between myth and realityZIMARINO, Marco; CALAFIORE, Antonio Maria; DE CATERINA, Raffaele et al.European heart journal. 2005, Vol 26, Num 18, pp 1824-1830, issn 0195-668X, 7 p.Article

Glycaemic control in acute coronary syndromes: prognostic value and therapeutic optionsDE CATERINA, Raffaele; MADONNA, Rosalinda; SOURIJ, Harald et al.European heart journal. 2010, Vol 31, Num 13, pp 1557-1564, issn 0195-668X, 8 p.Article

Long-term Use of Anti-inflammatory Drugs and Risk of Atrial FibrillationDE CATERINA, Raffaele; RUIGOMEZ, Ana; GARCIA RODRIGUEZ, Luís Alberto et al.Archives of internal medicine (1960). 2010, Vol 170, Num 16, pp 1450-1455, issn 0003-9926, 6 p.Article

Hepatocyte growth factor: Molecular biomarker and player in cardioprotection and cardiovascular regenerationMADONNA, Rosalinda; CEVIK, Cihan; NASSER, Maher et al.Thrombosis and haemostasis. 2012, Vol 107, Num 4, pp 656-661, issn 0340-6245, 6 p.Article

Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitorsRENDA, Giulia; ZURRO, Maria; ROMANO, Mario et al.British journal of clinical pharmacology. 2010, Vol 69, Num 3, issn 0306-5251, 303-306, 324 [5 p.]Article

Late coronary thrombosis after drug-eluting stent: stent vs patient-driven prescription of aspirin-clopidogrel combinationZIMARINO, Marco; RENDA, Giulia; MADDESTRA, Nicola et al.Thrombosis and haemostasis. 2004, Vol 92, Num 3, pp 668-669, issn 0340-6245, 2 p.Article

The adequacy of myocardial revascularization in patients with multivessel coronary artery diseaseZIMARINO, Marco; CURZEN, Nick; CICCHITTI, Vincenzo et al.International journal of cardiology. 2013, Vol 168, Num 3, pp 1748-1757, issn 0167-5273, 10 p.Article

Vasculoprotective potential of olive oil components : Virgin olive oil: its functional capacityANNUNZIATA CARIUCCIO, Maria; MASSARO, Marika; SCODITTI, Egeria et al.Molecular nutrition & food research (Print). 2007, Vol 51, Num 10, pp 1225-1234, issn 1613-4125, 10 p.Article

n-3 fatty acids in the treatment of diabetic patients : Biological rationale and clinical dataDE CATERINA, Raffaele; MADONNA, Rosalinda; BERTOLOTTO, Alessandra et al.Diabetes care. 2007, Vol 30, Num 4, pp 1012-1026, issn 0149-5992, 15 p.Article